1. S3 Level, AWMF Registry No. 015-062 (2020) Peri- and postmenopause—diagnosis and interventions. Guideline of the DGGG, SGGG and OEGGG. https://www.awmf.org/leitlinien/detail/ll/015-062.html
2. National Institute for Health and Care Excellence (NICE) Guideline (2015) Menopause Full Guideline, Methods, evidence and recommendations, Version 1.5. https://www.nice.org.uk/guidance/ng23/evidence/full-guideline-pdf-559549261
3. Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M, Bougatsos C, Nygren P (2005) Management of menopause-related symptoms. Evid Rep Technol Assess 120:p12
4. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Old EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC (2015) Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 175(4):531–539
5. AWMF Registernummer: 032/034-OL (2018) Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom, Langversion 1.0. http://www.leitlinienprogramm-onkologie.de/leitlinien/endometriumkarzinom/